UPM enters the biochemicals business by investing in a biorefinery at Leuna, Germany

Fraunhofer in Leuna

Finnish company UPM takes the next transformative growth step and enters the biochemicals business by investing in a biorefinery at Leuna, Germany. The biorefinery will produce a range of 100% wood-based biochemicals which enable a switch from fossil raw materials to sustainable alternatives in various consumer-driven end-uses. The investment opens totally new markets for UPM with large growth potential for the future.

Continue reading

The construction of Global Bioenergies’ demo plant in Leuna is completed

20161012_151848Global Bioenergies, the French biotech company that is developing a process to convert renewable resources into hydrocarbons through fermentation, announced yesterday that the construction of its demo plant, started mid-2015, is completed.

Continue reading

Global Bioenergies obtaines 4.4 million euro loan for its demo plant in Germany

image
Global Bioenergies' lab

Global Bioenergies, French biotech compamy that is developing a process to convert renewable resources into hydrocarbons through fermentation, announces having obtained a 4.4 million euro loan from a consortium managed by BNP Paribas, Société Générale, CIC and Bpifrance to complete the financing of its demo plant in Germany. The loan, reimbursable over 5 years, is covered by guarantee funds of the Ile-de-France Region. The construction phase began yesterday and will last one year.

Continue reading

Heinrich Hiesinger, ThyssenKrupp Ceo: “Industrial Biotechnology is part of our growth strategy”

Heinrich Hiesinger, ThyssenKrupp Ceo, in Leuna
Heinrich Hiesinger, ThyssenKrupp Ceo, in Leuna

Europe’s first multi-purpose fermentation plant for the continuous production of bio-based chemicals has been recently inaugurated in Leuna, Saxony-Anhalt (Germany). Built at a cost of around 20 million euros, the facility will enable the German multinational conglomerate corporation ThyssenKrupp, one of the world’s largest steel producers (more than 43 billion euros in revenue), to further expand its research and development activities in the area of biochemicals based on renewable raw materials.

Continue reading